GLP-1 therapies, or glucagon-like peptide-1 receptor agonists , represent a substantial shift in how we handle type 2 diabetes . These prescription drugs help imitating the body’s own GLP-1 process, https://pr8bookmarks.com/story21863405/glp-1-a-significant-advance-in-blood-sugar-care